The Journal of Experimental Medicine
BioLegend: Antibody Reagents
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 2 October 2006 doi:10.1084/jem.20311iti2
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 203, Number 11, 2393-2393
This Article
Right arrow Full Text (PDF, 1024K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Williams, R.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

IN THIS ISSUE

Keeping NF-{kappa}B in check

Figure 1
Cells lacking TRAF3 constitutively release active p52 NF-{kappa}B.

NF-{kappa}B, a central proinflammatory regulator, gets activated by TNF receptor–associated factors (TRAFs). But He et al. (page 2413) now report that one TRAF family member (TRAF3) instead negatively regulates an alternative NF-{kappa}B activation pathway.

Classical activation of NF-{kappa}B occurs by TRAF-controlled degradation of cytoplasmic inhibitory binding proteins, which leads to nuclear accumulation of the p50 forms of NF-{kappa}B. Activation can also occur by a recently discovered route requiring NF-{kappa}B–inducing kinase (NIK), which releases a different NF-{kappa}B complex, thus one containing p52.

It was known that, unlike other TRAFs, overexpression of TRAF3 does not induce the classical NF-{kappa}B pathway. By examining TRAF3-null mice (which die soon after birth), He et al. now show that cells from these mice have constitutively active noncanonical p52 NF-{kappa}B. This constitutive activation was associated with aberrant accumulation of NIK protein, but not mRNA, suggesting that TRAF3 blocks noncanonical NF-{kappa}B by reducing NIK protein stability.

Crossing the TRAF3–/– mice with mice that lacked p52 prevented their early death, showing that overactivity of p52 was, indeed, the cause of lethality. The final cause of death in TRAF3–/– mice is uncertain but is most likely due to over-inflammation caused by the unfettered activation of NF-{kappa}B-signaling. Formula



Ruth Williams

ruth.williams{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Rescue of TRAF3-null mice by p100 NF-{kappa}B deficiency
Jeannie Q. He, Brian Zarnegar, Gagik Oganesyan, Supriya K. Saha, Soh Yamazaki, Sean E. Doyle, Paul W. Dempsey, and Genhong Cheng
J. Exp. Med. 2006 203: 2413-2418. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF, 1024K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Williams, R.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS